Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ladrx Corp (LADX)

Ladrx Corp (LADX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ladrx Corp 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 USA

www.ladrxcorp.com Employees: 2 P: 310-826-5648

Description:

LadRx Corporation is a biopharmaceutical company. It engages in the discovery and development of therapeutics to treat patients with cancer. The company's advanced drug conjugate, aldoxorubicin that is in late-stage clinical trials is a version of anti-cancer drug doxorubicin. LadRx Corporation, formerly known as CytRx Corporation, is based in Los Angeles, California.

Key Statistics

Overview:

Market Capitalization, $K 365
Enterprise Value, $K -1,705
Shares Outstanding, K 495
Annual Sales, $ 0 K
Annual Net Income, $ 400 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -820 K
EBIT, $ -3,820 K
EBITDA, $ -3,810 K
60-Month Beta 1.51
% of Insider Shareholders 8.10%
% of Institutional Shareholders 0.00%
Float, K 455
% Float 91.90%
Short Volume Ratio 0.07

Growth:

1-Year Return 13.42%
3-Year Return -98.73%
5-Year Return -97.37%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 102.34%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.67 on 11/14/24
Next Earnings Date 11/12/24
Earnings Per Share ttm -5.65
EPS Growth vs. Prev Qtr 35.52%
EPS Growth vs. Prev Year -1.21%
Annual Dividend Yield 0.00%
Most Recent Dividend 0.249 on 03/07/08
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 05/17/23

LADX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -2,292.32%
Return-on-Assets % -202.21%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow 1.08
Price/Book N/A
Book Value/Share -3.50
Interest Coverage -1.11

LADX Dividends

Date Value
03/07/08 $0.2490
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar